Best Options Strategy for JNJ
Looking for the best options strategy for Johnson & Johnson (JNJ)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live JNJ option chain right now, and a simple map from your view on JNJ to the strategy that fits it. Model any of them in the calculator before you trade.
About JNJ
Johnson & Johnson (JNJ) is a major company in pharmaceuticals and medical devices. Options traders on JNJ tend to watch the drug pipeline, litigation and earnings, since these can drive large moves in the share price.
JNJ for options traders
Johnson & Johnson's options market reflects the company's defensive character: implied volatility is structurally low, anchored by diversified, recession-resistant revenue across pharmaceuticals and medical devices. The biggest IV spikes tend to cluster around quarterly earnings, major FDA rulings on key drug approvals, and — less predictably — headline litigation events, particularly large-scale product liability cases that can move the stock sharply on court decisions or settlement news. Because JNJ carries genuine legal tail risk, IV can gap higher on unexpected lawsuit developments even outside earnings season.
That persistently low baseline IV makes JNJ a go-to name for premium sellers. Covered calls are a natural fit for long-term shareholders who want to monetize slow-moving theta on a quality compounder. Short puts attract income-focused traders who welcome ownership at a discount. When IV does rise modestly into earnings, short strangles or iron condors with conservatively wide wings can harvest the subsequent compression without taking on excessive directional risk. Directional long calls or puts are generally expensive relative to JNJ's typical realized move, so defined-risk spreads are usually a more efficient vehicle when a directional view is warranted.
Today's top-scoring strategy for JNJ
Our engine ranks defined-risk strategies on the live JNJ chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $220 | $0.08 |
| Sell | 1× | PUT | $260 | $5.92 |
| Sell | 1× | CALL | $260 | $7.95 |
| Buy | 1× | CALL | $300 | $0.24 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $327 | −$2,627 | −$2,598 | −$2,552 | −$2,495 | −$2,429 |
| $314 | −$2,525 | −$2,444 | −$2,354 | −$2,263 | −$2,174 |
| $301 | −$2,143 | −$2,028 | −$1,922 | −$1,829 | −$1,753 |
| $288 | −$1,318 | −$1,263 | −$1,224 | −$1,202 | −$1,197 |
| $275 | −$264 | −$354 | −$452 | −$554 | −$655 |
| $262 | $376 | $175 | −$20 | −$203 | −$372 |
| $249 | $17 | −$117 | −$259 | −$401 | −$538 |
| $236 | −$1,058 | −$1,053 | −$1,060 | −$1,079 | −$1,110 |
| $223 | −$2,092 | −$2,008 | −$1,930 | −$1,861 | −$1,805 |
| $209 | −$2,569 | −$2,515 | −$2,453 | −$2,388 | −$2,322 |
| $196 | −$2,642 | −$2,635 | −$2,620 | −$2,596 | −$2,566 |
Live scan from 2026-08-17 · quotes delayed ~15 minutes
Historical backtest: how a Iron Butterfly on JNJ would have performed
We approximated a Iron Butterfly on JNJ, entered repeatedly over the past year (92 historical entries, each held to expiration) with Black-Scholes-modelled entry premiums. Here is how that would have played out on real JNJ price history — an educational backtest, not a prediction of future returns.
Approximate: entry premiums are modelled with Black-Scholes from trailing realised volatility, held to expiration and settled against the real historical close. Real fills, implied volatility and slippage differ — treat it as directional context, not exact returns.
Implied volatility
JNJ is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 23% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on JNJ currently price in about 23% implied volatility, versus roughly 23% the stock has actually realised over the past month. The two are roughly in line, so neither buying nor selling premium has a clear volatility edge here.
JNJ's IV Rank is 5/100: implied volatility sits 5% of the way between its 28-day low (22%) and high (31%), and is above 7% of recorded days. Premium is historically cheap, which favours net-debit strategies like long options and debit spreads.
Off that volatility, the options market is pricing a move of about ±$17.4 (±7%) in JNJ by 2026-09-18 — a range of roughly $244 to $279. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, puts and calls on JNJ carry a fairly symmetric implied volatility — no strong directional fear is priced in either way.
JNJ options chain highlights: open interest, volume and skew
The live JNJ options chain shows a put/call open-interest ratio of 0.6 (bullish-leaning (more calls)), with at-the-money implied volatility near 22.6%. Open interest clusters at the $270 call — a common resistance "wall" — and the $210 put, a support "wall": the strikes option writers are most exposed to into expiration.
Snapshot of open interest, volume and implied volatility for the nearest scanned expiration — context, not a trading signal.
JNJ insider trading activity (SEC Form 4)
Open-market insider transactions at JNJ over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| Broadhurst Vanessa | Sell | 23,054 | $5.8M | 2026-07-20 |
| Wengel Kathryn E | Sell | 10,000 | $2.4M | 2026-06-11 |
| Decker Robert J | Sell | 4,075 | $1.0M | 2026-02-27 |
| Schmid Timothy | Sell | 1,322 | $325K | 2026-02-20 |
Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.
JNJ congressional trading (STOCK Act)
Recent JNJ stock trades disclosed by members of the US Congress under the STOCK Act. Lawmakers must report trades within 45 days; amounts are disclosed only as broad ranges, and a trade is not an endorsement — treat it as context, not a signal.
| Member | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| Rich McCormick | House | Sell | $1,001 - $15,000 | 2026-07-30 |
| Ro Khanna (CA17) | House | Buy | $1,001 - $15,000 | 2026-07-02 |
| Thomas H. Kean (NJ07) | House | Sell | $1,001 - $15,000 | 2026-06-29 |
| Thomas H. Kean (NJ07) | House | Sell | $1,001 - $15,000 | 2026-06-02 |
Source: US House & Senate financial disclosures via Financial Modeling Prep. Amounts are the disclosed ranges. Informational context, not investment advice.
Liquidity and tradeability
JNJ options are reasonably liquid, with bid-ask spreads around 6.3% near the money. Defined-risk spreads and condors are workable; use limit orders and watch the fill on wider multi-leg trades.
Earnings & IV crush
JNJ's next earnings report is due around October 13, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Dividend and assignment risk
JNJ pays a dividend of about 2.1% a year, so short or covered calls on it carry early-assignment risk around each ex-dividend date — in-the-money calls are most exposed just before the stock goes ex-dividend.
Key figures
- Market cap
- $632.3B
- Beta (vs market)
- 0.23
- 52-week range
- $173.33–$274.90 (87% up the range)
- Short interest
- 1.2% of float · 3.2 days to cover
Other strong setups for JNJ
If your view on JNJ differs, these also scored well in the latest scan:
How to choose an options strategy for JNJ
Start with your outlook on JNJ, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while JNJ stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open JNJ in the free calculator →
Frequently asked questions
What is the best options strategy for JNJ?
It depends on your outlook. Bullish traders often use a long call or bull call spread on JNJ; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are JNJ options liquid enough to trade?
Johnson & Johnson (JNJ) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade JNJ options?
Buying a single JNJ call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade JNJ or any security. Do your own research.
What does Johnson & Johnson do?
Johnson & Johnson (JNJ) operates in the Drug Manufacturers - General industry. The "About Johnson & Johnson" section above gives a fuller picture of what the company does and how it earns money.
Does Johnson & Johnson pay a dividend?
Yes — Johnson & Johnson currently pays a dividend yielding about 2.1%. If you hold the shares (for example to write a covered call), the ex-dividend date can trigger early assignment, so check it beforehand.
When does Johnson & Johnson next report earnings?
Johnson & Johnson's next earnings are expected around October 13, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Price trend
Tickers related to JNJ
Comparing JNJ with similar names can help you choose the best options strategy:
Company information
- Headquarters
- One Johnson & Johnson Plaza, New Brunswick, NJ, 08933, United States
- Industry
- Drug Manufacturers - General
- Employees
- 138,200
- CEO
- Mr. Joaquin Duato
- Phone
- 732 524 0400
- Website
- www.jnj.com
- Investor relations
- www.investor.jnj.com/investor-relations.cfm
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.